
Peptide Category
Healing & Tissue Repair
The regenerative group: BPC-157, TB-500, and the multi-peptide blends built from them. Extensively studied in preclinical models; human evidence remains limited, and that distinction matters.
Complementary Mechanisms
BPC-157 is a synthetic pentadecapeptide derived from a protein found in gastric juice. Research has explored angiogenesis, collagen synthesis, gut mucosal protection, and modulation of dopaminergic and serotonergic signalling. It is among the most extensively studied peptides in preclinical regenerative research.
TB-500 is a synthetic analogue of Thymosin Beta-4, a 43-amino acid protein involved in actin sequestration and cell migration. Its high systemic distribution profile distinguishes it from more localised repair peptides.
The two are studied together often enough that the pairing has become a benchmark combination, with BPC-157 covering localised repair and TB-500 covering systemic distribution.
The Blends
GLOW 70 adds GHK-Cu to that pair, extending coverage into dermal collagen and elastin remodelling. KLOW 80 adds KPV as a fourth component. KPV is the C-terminal tripeptide fragment of alpha-MSH, carrying much of that hormone's anti-inflammatory activity through the NF-kB pathway. Each blend addresses a distinct node of the regenerative cascade in a single administration.
Reading the Evidence
Documented research areas include tendon and ligament repair, gastrointestinal mucosal healing, wound healing and angiogenesis, and inflammatory pathway modulation. Most of this sits in animal and early-stage models. The mechanisms are not yet fully mapped in human research, which is a genuine part of the picture rather than a footnote to it.
Supplied for laboratory research purposes only.
Research-Grade Compounds
Browse our catalog
All products are strictly for in vitro and in vivo laboratory research use only. Not for human therapeutic use.
View All Compounds